Home>

Products

Submit Request Quote
 * Denotes Required Field.
Name:
 *
Company Name:
Phone:
Email:
 *
Message:
Request Quote
 
Out Of Stock image

Is currently out of stock, however if you enter your email address we will notify you when it comes back into stock!

Continue shopping Get Notified

Anti-rhesus IgG1 [ena]-biotin

Anti-rhesus IgG1 [ena]-biotin
Product Type: Antibodies for Assays (In Vitro)
Format: Anti-rhesus IgG1-biotin, 7H11, mouse variable region, mouse IgG Fc
Clone ID: [ena]
RRID: AB_2819311
Common Names: Anti-rhesus IgG1 [ena]-biotin | Anti-rhesus IgG1 (isotype-specific)-biotin | 7H11-F1-C5 | Anti-rhesus IgG1 [7H11]-biotin | PR-7116
Target: IgG1
Reactivity: Rhesus Macaque (Macaca mulatta)
Applications: in vitro; ELISA
Description:

(*Formerly 7H11): mAb that reacts specifically with rhesus IgG1 with minimal reactivity to rhesus IgG2, IgG3, or IgG4. Tested in serum. *Subcloned from original 7H11 hybridoma.
Modifications: biotin
Restrictions: No
Sponsor: NIAID
How to cite (Methods): The Anti-rhesus IgG1 [ena]-biotin antibody was engineered and produced by the Nonhuman Primate Reagent Resource (NIH Nonhuman Primate Reagent Resource Cat#PR-7116,RRID:AB_2819311).
How to cite (Acknowledgments): The Anti-rhesus IgG1 [ena]-biotin antibody used in this study was provided by the NIH Nonhuman Primate Reagent Resource (NIAID U24 AI126683).

Reagent cost, which is the actual cost of production, is recovered for some reagents. Please inquire if you have questions about reagent cost recovery. Purchase order or credit card is NOW REQUIRED for cost-recovered reagents.

You are not authorized to purchase this product. Please ensure you are logged into your account.

CAN'T FIND EXACTLY WHAT YOUR RESEARCH REQUIRES?

Request a Reagent:

Would you like to see an NHP-specific antibody developed through the program? Suggest a new reagent that would benefit the NHP community.

REQUEST A REAGENT

The Nonhuman Primate Reagent Resource (NHPRR) is a nonprofit laboratory established in 1999, and supported by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), and Office of Research Infrastructure Programs (ORIP).

Copyright © 2004-2024